Today’s Top Story

Study Evaluates Operatively Treated Lateral Process of the Talus Fractures

A retrospective study published online in BMC Musculoskeletal Disorders analyzed patient-reported outcome measures in surgically treated fractures to the lateral process of the talus (LPTF). A total of 22 patients (mean age, 32 years) were treated surgically for LPTF and had at least one year of follow-up. Most patients (73 percent) had a Hawkins type 1 fracture, while 23 percent had a type 2 fracture and only one patient had a type 3 fracture. Overall, 82 percent of patients suffered concomitant injuries, and 9 percent had minor surgical side infections. Half of patients developed symptomatic subtalar osteoarthritis (OA). The overall mean visual analog scale foot and ankle (VAS-FA) score was 77, and the mean Karlsson Score was 72. Post-traumatic subtalar OA was predictive of poorer VAS-FA and Karlsson Score.

Read the study…

 
 
Other News

Study Tracks Curve Progression in AIS Patients after Sanders Stage 7

A retrospective review published in the June 7 issue of the Journal of Pediatric Orthopaedics found that female adolescent idiopathic scoliosis (AIS) patients with a curve > 40 degrees after Sanders Stage 7 (SS7) may be more likely to need surgery. The study group comprised AIS patients treated between May 2008 and May 2018 at a single institution who had SS7 as demonstrated by a hand radiograph and spine radiograph measuring < 50 degrees. Among the 89 patients included in the review, the average main curve magnitude was 33 degrees at SS7 and 38 degrees at two-year follow-up. About half of patients (n = 45, 51 percent) progressed ≥ 5 degrees, and just under a fifth (n = 17, 19 percent) progressed ≥ 10 degrees. Curves < 40 degrees at SS7 were observed in 70 patients, and after two years, 22 (31 percent) progressed to > 40 degrees. At follow-up, 11 patients (12 percent) underwent surgery or progressed to > 50 degrees. An association was observed between a 39.5 degrees curvature at SS7 and progression to > 50 degrees or surgery.

Read the abstract…

 
 
Study Finds No Association Between Ibuprofen Use and Colles Fracture Healing

A randomized, controlled trial published online in Injury found that ibuprofen does not impact bone healing in Colles fracture. Between June 2012 and June 2015, 95 patients (median age, 65 years) underwent external fixation for a displaced Colles fracture; 83 patients completed one-year follow-up. Patients were stratified into three groups: ibuprofen 600 mg three times a day for seven days; ibuprofen 600 mg three times a day for three days, followed by four days of placebo; and placebo for seven days. If needed, patients could take tramadol 50 mg. Radiological migration and pain scores did not largely differ between the treatment groups, and ibuprofen use had no effect on range of motion. The ibuprofen group had lower use of tramadol compared to the placebo group, and the complication rate was higher in the seven-day ibuprofen group compared to the placebo group. All patients saw improvements in Disabilities of the Arm, Shoulder and Hand score and wrist motion.

Read the abstract…

 
 
Study Assesses Correlation Between Neck and Post-concussion Symptoms

A prospective case series published online in the Journal of Orthopaedic & Sports Physical Therapy found a correlation between neck injury and post-concussion symptoms. A total of 20 patients who were a mean 7.5 weeks post-concussion but had persistent symptoms were evaluated by two multidisciplinary concussion service providers. The clinicians determined that 90 percent of patients had a neck problem that was related to their current symptoms. The mean moderate-severe neck disability index score was 33.4, and most patients (85 percent) experienced frequent neck pain.

Read the abstract…

 
 
 
Stem Cell Giant Pushes Companies to Include Stem Cell Therapy in Health Care Plans

Regenexx, one of the country’s dominant stem cell companies, has persuaded more than 100 employers in the United States to add its services to their health care plans. According to Regenexx, its services are significantly more affordable than surgical treatment options and can replace 70 percent of orthopaedic surgeries, a claim orthopaedic surgeon and researcher Freddie H Fu, MD, called “silly.” Other researchers along with insurance companies have criticized the use of stem cells as a replacement for surgery, citing lack of evidence for efficacy and wide variation in product.

Read more…

 
 
 
AAOS Now

Orthopaedic Hand Surgeon Turned State Senator Talks Politics

Douglas W. Lundy, MD, MBA, sat down for an interview with Georgia state Senator D. Kay Kirkpatrick, MD. Dr. Kirkpatrick provides insights on how and why a successful orthopaedic surgeon would leave the familiarity of medicine and enter the world of public service and politics.

Read more…

 
 
 
Your AAOS

Follow the Office of Government Relations on Twitter

Looking for AAOS Advocacy updates on Twitter? Follow the Office of Government Relations (@AAOSAdvocacy) for timely news and information. The Association arm of the Academy identifies, analyzes, and directs all health policy activities and initiatives to position the AAOS as the trusted leaders in advancing musculoskeletal health. Members are encouraged to follow this handle and engage with tweets to help promote the viewpoint of the orthopaedic community.

Follow @AAOSAdvocacy…

 

Leave a Comment

Error! This email is not valid.